Purchases and Sales Made in Q3 2022 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q3 2022. The information is specifically focused on institutions that hold shares of Day One Biopharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
231+ 18.1% |
$3.8K - $6.14K
|
1.51K
$18.7K
|
|
Oct 31, 2022
Q3 2022
|
Sg Americas Securities, LLC
|
BUY
|
- |
174+ 1.84% |
$2.86K - $4.62K
|
9.62K
$119K
|
|
Nov 10, 2022
Q3 2022
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
- |
134+ 582.61% |
$2.2K - $3.56K
|
157
$1.95K
|
|
Nov 07, 2022
Q3 2022
|
Bellevue Asset Management, LLC
Bellevue, WA |
BUY
|
- |
62New |
$1.02K - $1.65K
|
62
$769
|
|
Nov 14, 2022
Q3 2022
|
Virtus ETF Advisers LLC
New York, NY |
BUY
|
- |
50+ 0.76% |
$822 - $1.33K
|
6.6K
$81.9K
|
|
Nov 07, 2022
Q3 2022
|
Spire Wealth Management
|
BUY
|
- |
40New |
$658 - $1.06K
|
40
$496
|
|
Nov 02, 2022
Q3 2022
|
Ellevest, Inc.
|
BUY
|
- |
13+ 130.0% |
$214 - $345
|
23
$285
|
|
Nov 14, 2022
Q3 2022
|
Covestor LTD
Boston, MA |
BUY
|
- |
6New |
$98.6 - $159
|
6
$74.4
|
|
Oct 13, 2022
Q3 2022
|
Umb Bank, N.A.
|
BUY
|
- |
3New |
$49.3 - $79.7
|
3
$37.2
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 07, 2022
Q3 2022
|
Td Asset Management Inc
|
SELL
|
- |
-1- -0.0% |
$16.4 - $26.6
|
46.3K
$575K
|
|
Aug 11, 2023
Q3 2022
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-155- 0.27% |
$2.55K - $4.12K
|
57.5K
$712K
|
|
Nov 03, 2022
Q3 2022
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-155- 0.27% |
$2.55K - $4.12K
|
57.5K
$712K
|
|
Nov 14, 2022
Q3 2022
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-763- 5.09% |
$12.5K - $20.3K
|
14.2K
$177K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.56K- 41.71% |
$25.7K - $41.6K
|
2.19K
$27.1K
|
|
Nov 15, 2022
Q3 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-4.4K- 10.38% |
$72.3K - $117K
|
38K
$471K
|
|
Nov 02, 2022
Q3 2022
|
Summit Rock Advisors, LP
|
SELL
|
- |
-7.37K- 22.26% |
$121K - $196K
|
25.8K
$319K
|
|
Nov 10, 2022
Q3 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-10.1K- 43.91% |
$166K - $268K
|
12.9K
$160K
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-11K- 0.42% |
$181K - $293K
|
2.62M
$32.4M
|
|
Nov 14, 2022
Q3 2022
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-11.7K- 2.34% |
$193K - $311K
|
490K
$6.08M
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-11.9K- 19.82% |
$195K - $315K
|
47.9K
$595K
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-16.9K- 41.97% |
$278K - $449K
|
23.4K
$290K
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-18.7K- 16.06% |
$308K - $498K
|
97.9K
$1.21M
|
|
Nov 14, 2022
Q3 2022
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-75K- 34.54% |
$1.23M - $1.99M
|
142K
$1.76M
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-169K- 8.94% |
$2.78M - $4.5M
|
1.73M
$21.4M
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-169K- 8.94% |
$2.78M - $4.5M
|
1.73M
$21.4M
|
|
Nov 14, 2022
Q3 2022
|
Viking Global Investors LP
|
SELL
|
- |
-299K- 16.09% |
$4.91M - $7.94M
|
1.56M
$19.3M
|
|
Nov 09, 2022
Q3 2022
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-799K- 8.91% |
$13.1M - $21.2M
|
8.17M
$101M
|
|
Nov 14, 2022
Q3 2022
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-2.48M- 70.62% |
$40.8M - $65.9M
|
1.03M
$12.8M
|
|
Oct 31, 2022
Q3 2022
|
Canaan Partners Xi LLC
Menlo Park, CA |
SELL
|
- |
-2.7M- 27.93% |
$44.4M - $71.7M
|
6.96M
$86.4M
|